Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N F Kalkers

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot studyN F Kalkers, F Barkhof, E Bergers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissueN F Kalkers, H Vrenken, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosisE L Hoogervorst, N F Kalkers, van Winsen LML, et al.
Neurology|September 26, 2001
TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MSJ Killestein, N F Kalkers, J F Meilof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2004
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional CompositeE L J Hoogervorst, N F Kalkers, G R Cutter, et al.
Multiple Sclerosis and Related Disorders|November 16, 2019
Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision makingC E P van Munster, L Kaya, K H Lam, et al.
Neurology|April 11, 2001
Comparisons of patient self-report, neurologic examination, and functional impairment in MSE L Hoogervorst, L M van Winsen, M J Eikelenboom, et al.
Multiple Sclerosis and Related Disorders|April 14, 2022
Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosisP C G Molenaar, E M M Strijbis, C E P van Munster, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Multiple sclerosis functional composite: impact of reference population and interpretation of changesB M J Uitdehaag, H J Adèr, T J A Roosma, et al.
Neurology|April 4, 2000
MS functional composite: relation to disease phenotype and disability strataN F Kalkers, V de Groot, R H Lazeron, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot studyN F Kalkers, F Barkhof, E Bergers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissueN F Kalkers, H Vrenken, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosisE L Hoogervorst, N F Kalkers, van Winsen LML, et al.
Neurology|September 26, 2001
TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MSJ Killestein, N F Kalkers, J F Meilof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2004
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional CompositeE L J Hoogervorst, N F Kalkers, G R Cutter, et al.
Multiple Sclerosis and Related Disorders|November 16, 2019
Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision makingC E P van Munster, L Kaya, K H Lam, et al.
Neurology|April 11, 2001
Comparisons of patient self-report, neurologic examination, and functional impairment in MSE L Hoogervorst, L M van Winsen, M J Eikelenboom, et al.
Multiple Sclerosis and Related Disorders|April 14, 2022
Cross-sectional and longitudinal correlations between the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) and other outcome measures in multiple sclerosisP C G Molenaar, E M M Strijbis, C E P van Munster, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Multiple sclerosis functional composite: impact of reference population and interpretation of changesB M J Uitdehaag, H J Adèr, T J A Roosma, et al.
Neurology|April 4, 2000
MS functional composite: relation to disease phenotype and disability strataN F Kalkers, V de Groot, R H Lazeron, et al.
Pageof 3